Mein Warenkorb

CD9

CD9 Molekülinformation

Englischer NameCD9 antigenAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1Target-AliasMotility Related Protein-1,Leukocyte Antigen MIC3,Tetraspanin-29,5H9 Antigen,CD9 Molecule,TSPAN29,MRP-1,Cell Growth-Inhibiting Gene 2 Protein,MIC3,Motility-Related Protein,P24,BA-2/P24 Antigen,Antigen CD9,TSPAN-29,Tspan-29,DRAP-27,BTCC-1,CD9,BA2
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Englischer NameCD9 antigen
Target-AliasMotility Related Protein-1,Leukocyte Antigen MIC3,Tetraspanin-29,5H9 Antigen,CD9 Molecule,TSPAN29,MRP-1,Cell Growth-Inhibiting Gene 2 Protein,MIC3,Motility-Related Protein,P24,BA-2/P24 Antigen,Antigen CD9,TSPAN-29,Tspan-29,DRAP-27,BTCC-1,CD9,BA2
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical

CD9 Produktliste

  • Attribut

    Protein (4)

  • Produktbibliothek

    Online (4)

  • Spezies

    Human (4)

  • Etikett

    His Tag (1)His Tag & Avi Tag (1)- (1)His Tag & Flag Tag (1)

  • Marker

    Unconjugated (3)Biotin-labeled (1)

CD9 Molekülhintergrund

CD9 antigen is also known as tetraspanin-29 (TSPAN29), 5H9 antigen, Leukocyte antigen MIC3 (MIC3), Motility-related protein, is a multi-pass membrane protein which belongs to the tetraspanin (TM4SF) family or the transmembrane 4 superfamily. CD9 is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. TSPAN29 is found on the surface of exosomes. MIC3 Involved in platelet activation and aggregation, regulates paranodal junction formation and also Involved in cell adhesion, cell motility and tumor metastasis. CD9 antigen also seems to be a key part in the egg-sperm fusion during mammalian fertilization

CD9 Molekülalias

CD9,MIC3,TSPAN29,GIG2,MRP1,BTCC1,DRAP27,5H9

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
KBA-1412KBA-1412; KBA1412; AT-1412Phase 1 ClinicalAimm TherapeuticsSolid tumours
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns